Zelluna ASA Reports Second Quarter 2025 Financial Results and Provides General Business Update
Zelluna ASA Oslo, Norway, 20 August 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T-cell receptor-based…
Browsing Tag